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ABSTRACT
The ability to induce gene expression in a small
molecule dependent manner has led to many applica-
tions in target discovery, functional elucidation and
bio-production. To date these applications have re-
lied on a limited set of protein-based control mech-
anisms operating at the level of transcription initia-
tion. The discovery, design and reengineering of ri-
boswitches offer an alternative means by which to
control gene expression. Here we report the develop-
ment and characterization of a novel tunable recom-
binant expression system, termed RiboTite, which
operates at both the transcriptional and translational
level. Using standard inducible promoters and or-
thogonal riboswitches, a multi-layered modular ge-
netic control circuit was developed to control the ex-
pression of both bacteriophage T7 RNA polymerase
and recombinant gene(s) of interest. The system was
benchmarked against a number of commonly used
E. coli expression systems, and shows tight basal
control, precise analogue tunability of gene expres-
sion at the cellular level, dose-dependent regulation
of protein production rates over extended growth pe-
riods and enhanced cell viability. This novel system
expands the number of E. coli expression systems
for use in recombinant protein production and rep-
resents a major performance enhancement over and
above the most widely used expression systems.
INTRODUCTION
Most inducible bacterial recombinant expression systems
operate at the transcriptional level. An example is the E.
coli BL21(DE3) strain, which utilizes the T7 bacteriophage
RNA polymerase (T7 RNAP) in combination with expres-
sion vectors containing the T7 promoter. This system is
widely used despite the well-studied issues of leaky basal
expression and heterogeneous induction response (1). In-
ducible microbial recombinant expression systems often
display either an all-or-none response with limited titrata-
bility, or a heterogeneous response to induction within a
host cell population (2,3). This can be troublesome for the
production of technically challenging proteins, where, e.g.
aggregation, toxicity and/or solubility are an issue (1). Fur-
thermore, high levels of recombinant expression are known
to lead to over utilization of cellular resources, metabolic
burden, ribosome destruction and compromised cell viabil-
ity (4,5). In addition to the effects of the recombinant sys-
tem upon the cell, cell physiology and stress can affect the
functionality (6) and stability (7) of recombinant systems.
Various methods to alleviate some of these limitations have
been attempted, either at the transcriptional level, e.g. by
use of tight promoters (1), or at the protein level, e.g. by al-
losteric repression/regulation of T7 RNAP (8,9). However,
further development work is required to overcome many
of these issues, for a range of recombinant protein produc-
tion applications, metabolic engineering and synthetic biol-
ogy efforts. Enabling expression to be matched to the cel-
lular processing capacity, and/or toxicity thresholds would
be optimal to avoid a waste of cellular resource allocation,
and tomaximize titre and yield of the target protein of inter-
est. To permit matching of expression to capacity, inducible
recombinant expression should ideally be regulated over a
broad dynamic range, and with a robust analogue (tune-
able) dose-response. By definition analogue dose-response
curves are less sensitive to: (i) local fluctuations in acti-
vators (inducers) due to differential uptake/diffusion, (ii)
metabolic heterogeneity resulting in fluctuations in catabo-
lite levels, and (iii) transcriptional bursts and stochastic fluc-
tuations in basal expression (10). Further from an operator
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level an analogue response is more robust and less sensitive
to small errors in the manual addition of inducers, and thus
permits greater precision and reproducibility.
Nature has developed a wide range of post-
transcriptional control mechanisms by which to regulate
gene expression, including: tRNA sensing (11,12), ncRNA
(13), riboswitches (14), viral pseudoknots (15), ribosome
pausing (16) and allosteric protein inhibition (8). Taking
a lead from nature we identified the naturally occurring
metabolite-responsive riboswitches as promising gene
regulatory devices (14). Riboswitches are mostly found in
the 5′ UTR of bacterial mRNAs, where they have been
shown to operate via a number of mechanisms, including
translation initiation, transcription termination or mRNA
cleavage mechanisms (17–19). Upon binding to a specific
metabolite, riboswitches change conformation, permitting
differential gene regulation to occur (17). This is a funda-
mentally different regulatory paradigm from that widely
used in inducible promoter recombinant systems, therefore
riboswitches present themselves as attractive targets for
use as novel genetic control elements (7). Previously, we
re-engineered the Add-A translational ON riboswitch to
no longer bind to its cognate metabolite, but instead to
a synthetic inducer (20). Further, we demonstrated that
the orthogonal riboswitch can control heterologous gene
expression in vivo (20,21).
Here using both an inducible promoter and the previ-
ously developed orthogonal riboswitch (20), we developed
a dual transcriptional-translational ON device to directly
control the expression of both T7 RNAP, and the recom-
binant gene of interest in an E. coli host. This recombinant
expression system, termedRiboTite, has been benchmarked
against a number of the commonly used E. coli expres-
sion systems and strains (BL21(DE3), BL21(DE3)pLysS,
LEMO21(DE3), KRX and pBAD) with the eGFP reporter
gene, using in-depth biochemical and mathematical perfor-
mance analysis. In addition the potential of the novel ex-
pression system has been demonstrated with the toxic gene
sacB, the antimicrobial peptide epidermicin NI01, which is
toxic to E. coli during recombinant expression, and clini-
cally important targets (scFv, IFN2a, p53, MTH1).
MATERIALS AND METHODS
All cells were grown in TB (2.7% yeast extract, 4.5% glyc-
erol, 1.3% Bactotryptone) or LB medium (0.5% yeast ex-
tract, 0.5%NaCl, 1.0% Bactotryptone), supplemented with
0.2% glucose. A Biotek Synergy HTMicroplate Reader was
used to measure the GFP fluorescence and OD600 for intact
cells.
Strains, plasmids, kits, inducers
BL21(DE3) (Novagen), BL21 parental (Bioline),
LEMO21(DE3) (NEB), pLysS (Novagen), KRX (Promega),
pBAD (Life Technologies) pMOD3, EzTn5 kit (Cam-
bio). pET15b-eGFP, pET15-sacB and genes for: scFv,
IFNa2a, MTH1, p53 (GeneArt). IPTG (Isopropyl -D-
1-thiogalactopyranoside) (Sigma), rhamnose (Sigma),
arabinose (Sigma), PPDA - Pyrimido[4,5-d]pyrimidine-
2,4-diamine (Peakdale Molecular). Ampicillin (Sigma),
Chloramphenicol (Sigma).
Primers
1f: AAAAACCATGGCCACGATTAACATCGCTAA
GAACGAC
1r: TTTTGCGGCCGCTTACGCGAACGCGAAGTC
CGAC
2f: AAAGAATTCACACCATCGAATGGTGCAAA
2r: TTTGAATTCGGTGCCTAATGAGTGAGCTA
3f: ATCCGAATGATATGGTTTCG
3r: TCCATGCCGAGAGTGATCCC
Strain and vector engineering
T7 RNAP was PCR amplified (p1f/r), restriction digested
and ligated into the pMOD3-M6′′-spDsRED plasmid (pre-
viously assembled using the reported method (21)), via
NcoI/NotI to afford pMOST [pMOD3-lacWT P/O-ORS-
spT7RNAP]. Note that M6′′ and ORS (orthogonal ri-
boswitch) are equivalent. To permit the subsequent transfer
of the construct into a variety of genetic locations, with both
different vector backbones and stable chromosomal inser-
tions, we sought to provide the system with a proximal copy
of the transcriptional repressor gene (lacI). lacI was am-
plified (p2f/r) and cloned into the pMOST vector (EcoRI
site) to afford clones pMLOSTf and pMLOSTr, with the
lacI gene upstream from the ORS-T7RNAP system in both
forwards and reverse directions, respectively.
To permit greater flexibility, and to avoid the cellular
burden of maintaining two plasmids, we sought to de-
velop a strain with a stable chromosomal insertion of the
functional constructs. Firstly, the pMLOSTf construct was
linearized with flanking IS sites by restriction digestion
(PshAI), then using the EZ-Tn5 transposon system (Epi-
centre). The parental BL21 strain was transformed with
the transposons, and selected for with the kanR marker.
Transformants were confirmed by colony PCR, and res-
cue cloning into a pir+ strain confirmed both a single in-
sertion per cell and the chromosomal location (DMSO re-
ductase gene) of the insertion, in the resultant strain named
BL21(IL3). The strain was used for subsequent analyses.
The strains BL21(DE3) and BL21(IL3) provide an ideal
system to compare the (+/−) effect of the riboswitch con-
trol of T7 RNAP, as the genetic backgrounds are essentially
identical, and the T7 RNAP regulatory inserts contain sim-
ilar design elements.
The ORS was amplified (p3f/r) and cloned into the plas-
mid pET15b-eGFP (XbaI/NcoI sites), to create the plas-
mid pETORS′-eGFP. The NcoI site in this plasmid was
subsequently removed by site-directed mutagenesis (Qia-
gen), to establish the correct nucleotide sequence between
the RBS and AUG start codon, this afforded the plasmid
pETORS-eGFP. The plasmid pETORS-eGFP was trans-
formed into the BL21 (DE3) and BL21 (IL3) strains. BL21
(DE3) and BL21 (IL3) bearing the pETORS-eGFP plas-
mid showed one and two layers of control respectively in
a classical PT7 driven expression system. A series of syn-
thetic genes (GENEART) were cloned into pET15b-eGFP
(a kind gift from Tim Eyres, Manchester), and pETORS-
eGFP expression vectors, using theNdeI/BamHI restriction
enzyme sites. The sequences of IFN 2α and scFvwere a kind
gift from Cobra Biologics. Epidermicin NI01 (22) was sub-
cloned from pET28 NI01 (22) into pETORS via the NcoI
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and BlpI sites. eGFP was sub-cloned into the pBAD vector
via the XbaI and BlpI sites.
Expression induction procedure
LBmedia pre-cultures were inoculated directly from freshly
plated single colonies for each of the systems, grown for
16 h, and diluted 1:100 in TB + 0.2% glucose with appro-
priate antibiotics, and growth was monitored at 37◦C with
shaking. For the multiwell scale, 400 l cultures in early-
logarithmic phase (∼0.3 OD600) were transferred to deep-
well plates, containing a matrix of inducer concentrations
and incubated at 30◦C with shaking at 1000 rpm (Stuart
microtitre plate shaker incubator). For Ultra-Yield (UY)
flasks scale 30 ml of cultures in early-logarithmic phase
(∼0.8 OD600) were transferred to 125 ml UY flasks contain-
ing the appropriate combination of inducers. Induced cul-
tures were grown at 20, 30 or 37◦C in a shaking incubator
(210 rpm) for up to 20 h.
Expression analysis and quantification
Cells were harvested and washed twice in PBS/0.2% tween.
Relative fluorescence units (RFU) and OD600 were mea-
sured by multimode plate reader. RFU/OD were plotted
to compare the effect of the various combinations of in-
ducer concentrations. For SDS-PAGE and western blot
analysis, OD-normalized volumes were collected and re-
suspended in SDS-PAGE loading buffer. Equal volumes
were loaded, separated by SDS-PAGE, and target pro-
teins confirmed by western blot. Membranes were blocked
with 5% skimmed milk in PBS/0.2% tween. eGFP was de-
tected with mouse monoclonal Anti-His antibody (Pierce
1:3000 in 5% skimmed milk) and donkey anti-mouse HRP-
conjugated secondary antibody (1:10 000 in 5% skimmed
milk). Anti-RNA polymerase 70 (Pierce 2G10) was used
as a loading control. After incubation with HRP substrate,
chemiluminescence was captured on film, and signal inten-
sity analysed by densitometry (ImageJ software). Two cal-
ibration curves were constructed: (i) Western blot signal
intensity versus purified eGFP standard (70–500 ng); (ii)
RFU from a selection of experimental samples versus ng
protein (converted using calibration curve (i)). The full ex-
perimental data set was converted from RFU to ng protein
using calibration curve (ii).
Data processing and statistical analysis
Normalized fluorescence measurements (RFU/OD) were
exported from the microplate reader datasheets into Ori-
gin (OriginLab). Each data point was the mean of at least
two biological experimental repeats (n≥ 2), and was used to
create Bivariate-dose gene expression matrices, or for curve
fitting using a four-parameter logistic function. Error bars
show calculated standard errors.
FACS
E. coli BL21 (DE3) pET15b-eGFP and E. coli BL21 (IL3)
pETORS-eGFPwere grown to early-logarithmic phase and
induced overnight at 30◦C with 50 M IPTG (DE3 strains)
and 50 M IPTG with varying PPDA concentration (IL3
strains). Induced cells were washed once in PBS then di-
luted 1/1000 in PBS. Flow Cytometry was performed using
a Sony SH800 Cell Sorter (Sony Biotechnology) equipped
with a 488 nm laser, enabling excitation of eGFP, with sub-
sequent emission being measured through use of the FL2
Channel (525/50 nm). Data were recorded for 100 000 cells
per sample at≤5000 events s−1 and analysed using FCS Ex-
press 4 Flow Cytometry (De Novo Software). Histograms
of events versus eGFP fluorescence were plotted and used
to determine mean fluorescence and coefficients of varia-
tion (CV) for the total population and gated subpopulations
consisting of non-fluorescent and fluorescent cells. Addi-
tionally the percentage of total events falling within each
gated sub-population was recorded. In the case of overlaid
histograms, the FCS Express for Flow cytometry smooth-
ing function was applied at factor 2, to allow easy visualiza-
tion of individual lines.
SacB assay
Overnight cultures (diluted 1:100) were grown at 37◦C, and
inducers were added (IPTG 50M and 200 M PPDA) as
required at OD600 = 0.7; the cells were then grown for a fur-
ther 3 h. 10 l drops of serial diluted (1:10) cultures were
spotted on agar plates containing the inducers as required,
in the presence and absence of 5% sucrose. Colony form-
ing was observed after incubation overnight at 37◦C. The
colonies were counted and normalized for OD= 1.0, to cal-
culate the normalized colony forming unity (CFU/ml).
Preparation of SDS samples for soluble/insoluble fraction
analysis
Samples were collected after 3 and 20 h of induction, and
equivalent number of cells were pelleted down and re-
suspended in 0.3 ml of lysis buffer (20 mM Tris pH 8500
mMNaCl, 0.2 mg/ml lysozyme) supplemented with DNA-
seI (NEB) and protease inhibitors (Roche). The samples
were incubated on ice for 30’, sonicated, and then were spun
down at 14 000 rpm for 10’ at 4◦C. The supernatant was
collected (soluble fraction), whereas the pellet was washed
twice in PBS and then re-suspended in 0.3 ml of PBS (insol-
uble fraction). After adding equal volume of 2xSDS-PAGE
loading buffer, the fractions were boiled for 10’ at 100◦C
and ran on a 4–20% SDS-PAGE gel (NuPAGE).
LDH assay
LDH Cytotoxicity Assay was performed according the
manufactory instruction (Pierce). The data are shown as a
percent of LDH activity (A490–630) from cell-free media rel-
ative to the activity from chemically lysed cells.
Clinical protein expression
Overnight cultures (diluted 1:100) were grown in UY flasks
and inducers were added (IPTG 50 M with various con-
centrations of PPDA) as required at OD600 = 0.8. Most of
the cultures were grown at 37◦C in a shaker-incubator for 3
h after induction. Only for ScFv gene expression, the cells
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were grown at 30◦C for 3 or 20 h. Protein expression was
detected by standard western blot procedure, using the an-
tibodies described in Expression analysis and quantification
method.
Epidermicin quantitation
Expression levels were determined by quantitation of stain-
free SDS-PAGE in-gel fluorescence (Bio-Rad), band inten-
sity was normalized to total lane intensity and quantitated
using the Image J software.
RESULTS
Translational control over T7 RNAP
We wished to deploy the Pyrimido[4,5-d]pyrimidine-
2,4-diamine (PPDA) inducible orthogonal riboswitch
(ORS) (23) in conjunction with the IPTG inducible lac
promoter/operator (P/Olac), to achieve dual transcrip-
tional and translational control over T7 RNAP expression.
We placed the ORS between a P/Olac and the T7 RNAP
gene, so that this enzyme requires induction by both IPTG
and PPDA to be expressed effectively; this construct was
inserted into the chromosome of the parental BL21 strain
(Figure 1A, Materials and Methods). This strain, termed
BL21(IL3), should effectively act as a Boolean AND logic
gate, as it requires two inputs (IPTG and PPDA) to produce
an output (T7 RNAP). The strain was transformed with a
plasmid (pET-eGFP) containing the eGFP gene controlled
by T7 RNAP promoter/lac operator hybrid (PT7/Olac), to
generate a system exhibiting transcriptional (t) and trans-
lational (T) control over T7 RNAP, and transcriptional
control (t) over the eGFP gene, named tT/t. Bivariate-dose
gene expression analysis revealed dose-dependent eGFP
expression in response to both inducers (Figure 1B). Fur-
thermore, regulatory control levels (max/basal) were high
at both 3 h (>400-fold), and 20 h post induction (56-fold)
(Supplementary Figure S1 and Table S1). These large
induction ratios were attainable due to the tight control
over basal expression in the absence of induction.
By fitting the dose-response data with a four-parameter
logistic function, both the half-maximal effective concen-
tration (EC50), and the dynamic range of ligand response
(DRLR; EC90/EC10) were determined. For IPTG titra-
tion the tT/t system demonstrated intermediate digital-
analogue (tuneable expression) response profiles (DRLR
ca. 15), independently of PPDA (Supplementary Table S2).
Increasing PPDA (fixed) resulted in a vertical extension of
the IPTG response curves, with little effect observed upon
basal expression (Figure 1C) (24). In contrast, for PPDA
titration the system exhibited classical analogue behaviour
(DRLR= 79) at IPTG 40M, and aDRLR ca. 50 at IPTG
≥ 200M(Supplementary Table S2). In addition, EC50 val-
ues were dramatically affected and an increase in both basal
and maximal expression levels was observed (Figure 1D).
This tuning of the PPDA response at different IPTG con-
centrations allows for both vertical and horizontal scaling
of the PPDA dose response curves, where the basal and
maximal expression levels can be changed, and also the win-
dow of PPDA sensing can be modestly expanded or con-
tracted.
Benchmarking standard transcriptional control
To evaluate the performance of the ORS control over T7
RNAP in the tT/t system, we used the BL21(DE3) strain,
that expresses T7 RNAP from the lacuv5 P/Olac, and trans-
formed it with the pET-eGFP plasmid (Figure 1A). This
system with just transcriptional control over the T7 RNAP
and eGFP genes was named t/t (Figure 1A). IPTG induced
eGFP expression in a dose-dependent manner (Figure 1E),
with a maximal expression output similar to the tT/t sys-
tem; however, basal expression in the absence of IPTG was
much higher, affording a modest 65-fold induction (Supple-
mentary Table S1). This basal expression increased dramat-
ically with time affording only ca. 3-fold after 20 h. In this
instance, basal expression is the result of leaky transcription
from P/Olac in the absence of IPTG. PPDA had no effect on
these cells, either in terms of eGFP expression or cell growth
(data not shown). The DRLR covered just a 10-fold range
of IPTG concentration, indicative of a digital (ON/OFF)
response (Figure 1F and Supplementary Table S2) (25).
Dual orthogonal riboswitch control
To achieve greater regulatory control, we additionally
placed the ORS between the T7 promoter and the eGFP
gene, replacing the original 5′ UTR, to create the pETORS-
eGFP plasmid (Materials and Methods). The BL21(IL3)
strain was transformed with this plasmid, creating an ex-
pression system that combines dual input transcriptional-
translational control over T7 RNAP expression, with a
further dual transcriptional-translational control over the
target gene output (Figure 1A). This tT/tT system offers
exceptional dose-dependent response to both inputs (Fig-
ure 1G), with ca. 850-fold inductionmaximum observed 3 h
post induction, and with an impressive ca. 330-fold induc-
tion maximum observed after 20 h, compared to 65- and
3-fold control of the t/t system (Supplementary Table S1).
The maximal eGFP expression output was reduced to ca.
70% compared to the t/t system, however basal expression
for the tT/tT system was especially low representing just ca.
0.1% of the maximal expression level.
For IPTG titration both the EC50 (87–149 M) and
DRLR values (18–22-fold) are only modestly influenced by
PPDA at the fixed concentrations tested (Figure 1H). Here
essentially by adjusting solely the maximal output, without
affecting the basal expression level, the additional transla-
tional control acts as a rheostat, by acting as an adjustable
point of resistance through the regulatory cascade. When
fully induced by IPTG (1 mM), the PPDA EC50 was 66
M with a 70-fold DRLR (Figure 1I), and these values re-
sponded to IPTGwith inversely proportional behaviour, al-
lowing for horizontal scaling of the dose response curves. At
low IPTG concentrations (40 M IPTG) the analogue be-
haviour was most pronounced with the DRLR covering a
245-fold range of PPDA concentration (Supplementary Ta-
ble S2). As with the tT/t system, both vertical and horizon-
tal scaling of the PPDA dose response curves is observed,
and additionally here the tT/tT system allows the window
of PPDA sensing to be greatly expanded or contracted.
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Figure 1. Construct Design and Multi-variant expression analysis. (A) the orthogonal riboswitch (ORS)-containing BL21(IL3) and standard BL21(DE3)
E. coli expression strains, with complementary expression plasmids pET and pETORS bearing the eGFP gene. (B–I) eGFP expression matrices and dose
response curves, for relative fluorescent units (RFU) normalized to cell density (OD600) under different inducer concentrations at 30◦ C, 3 h post induction
for the systems: tT/t (B–D), t/t (E–F) and tT/tT (G–I). Dose response curves were fitted to a four-parameter logistic function. The data represent the mean
of at least two replicates with error bars showing standard errors.
Global performance modelling
The cascade control elements of the tT/tT system were
categorized as two Boolean logic gates where gate one re-
quires 2-inputs (IPTG and PPDA) to produce an output
(T7 RNAP), and the second gate requires 3-inputs, both
inducers (IPTG and PPDA) and T7 RNAP from the first
gate, to produce the output (eGFP). For simplicity the sys-
tem can be considered as operating overall with AND logic
(Figure 2A). Truth tables were constructed to determine the
operating function of the two inputs upon the various sys-
tems. Using a 10% threshold cut-off only the tT/tT system
operated with ANDBoolean logic, whereas the tT/t system
was effectively an IPTG-only responsive gate (Figure 2B).
However, this digital-type analysis belies the synergistic am-
plification (A-OUT) effect of using multiple layers of regu-
latory control. Here the performance output of tT/t with
both inputs was greater (x3) than the sum of the individual
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Figure 2. AND gate performance modelling. (A) Diagram and equation of the modular AND gate designed on the basis of the AND model presented
in Kirouac et al. 2013, with a modification of the equation to allow for leaky expression in absence of PPDA (P), where y0 is the basal level of expression
(RFU/OD) in the absence of both IPTG (I) and P, y is the level of expression under saturation concentrations of both I (x1) and P (x2), n is the Hill
coefficient and K1 and K2 are the EC50 values for I and P, respectively. The fraction of expression that occurs independent of P is determined by f1, such as
when f1 = 1, expression is P-independent and when f1 = 0, the system behaves like a strict AND gate. The reciprocal, 1/f1, describes the enhancement in
expression obtained under saturating I and P relative to that obtained with only I. (B) truth tables for the logic displayed by each expression system with
an output defined with a 10% threshold cut off (D-OUT) and with an amplified output (A-OUT) showing the synergistic enhancement of using two inputs
together over the sum of individual inputs [A-OUT = (I+P) / ((I)+(P))] with bar graphs of the measured output levels (RFU/OD). (C) Contour plots of
the modelled I and P response for each expression system using the equation described in (A), black lines indicate the 10%, 50% and 90% contours. (D)
Table of the global fitting parameters. The data represent the mean of at least two replicates with error bars showing standard errors.
induction inputs, and this synergistic amplification of input
response was even greater (x9) when an additional ORS de-
vice was used in the tT/tT system.
A previously developed quantitative AND logic gate
model (26)wasmodified to allow for ‘leaky’ expression, here
permitting both single and dual-inputs to be assessed us-
ing a logistic Hill-type fitting parameter model (Figure 2A).
Global EC50 values were determined for all systems (Figure
2C and D and Supplementary Figure S2). Higher EC50 val-
ues were observed upon the addition of regulatory control
elements (t/t < tT/t < tT/tT), indicative of the additional
regulatory checkpoints. The proximity of the EC10 and
EC90 contours (Figure 2C) for t/t indicates a digital ON-
OFF response of the transcriptional control, whereas the
broader contour separation for tT/tT can be used to pre-
select the optimal combination of inducers to achieve a de-
PAGE 7 OF 14 Nucleic Acids Research, 2016, Vol. 44, No. 3 e21
sired level or titratable window of expression. The fraction
of eGFP expression that occurs independently of PPDA (f1)
for each system indicates that themodel was consistent with
the experimental data (Figure 2D). Indeed, the reciprocal
(1/f1), which describes the enhancement in expression rela-
tive to IPTG induction alone, was 3-fold for the tT/t and 12-
fold for the tT/tT systems. Further, the model indicates the
copy number (t/t < tT/t < tT/tT), and positional (genome
(tT/t) versus plasmid (t/tT)) effects of the ORS transla-
tional control device, where control of T7 RNAP is clearly
the regulatory bottleneck within the synthetic cascade.
Comparison against other tight expression systems
To more fully compare the expanded dynamic range and
tight basal expression of the tT/tT system against other
commonly used E. coli expression systems, we performed
side by side analysis against T7 RNAP based systems
that have been developed to reduce the basal leakage:
BL21(DE3)pLysS (LysS), which constitutively expresses
the T7 RNAP inhibitor T7 lysozyme (27), LEMO21(DE3)
(Lemo) (9) based on the rhamnose inducible expression of
a T7 lysozyme variant (LysY), the KRX strain based on
the rhamnose inducible promoter (rhaPBAD) (4,6). In ad-
dition we also compared the non-T7 RNAP pBAD sys-
tem (pBAD), based on the arabinose inducible promoter
(araPBAD) (28,29). We initially compared the regulatory
control (max/basal) andmaximal output in small-scale cul-
tures at short induction times (Supplementary Table S3).
The t/t and KRX systems displayed the smallest window of
regulatory control of 65- and 117-fold, respectively, Lemo,
pBAD and LysS displayed modest dynamic ranges 315-,
387- and 459-fold, respectively, compared to the tT/tT sys-
tem which displayed 845-fold. In terms of maximal expres-
sion under multiwell conditions, the systems based on the
BL21(DE3) strain (t/t, LysS, Lemo) produced similar high
expression levels (∼74–100%), with tT/tT and pBAD ex-
pressing∼50% and∼70%, respectively, andKRXproduced
the least (∼40%). In terms of relative basal control, t/t ex-
hibited the greatest basal leak, followed by KRX and Lemo
which exhibited only ca. 3-fold tighter basal control relative
to t/t. LysS and pBAD displayed a ca. 6.5-fold reduction
in basal, and tT/tT demonstrated the tightest control of all
with ca. 20-fold tighter basal control relative to t/t.
The relative tunability of the various expression systems
was assessed using bivariate matrix analysis (Supplemen-
tary Figure S3), and the dose-response data (Table 1 and
Supplementary Table S4). Titration of the LysS system pro-
duced a DRLR of 5.8-fold indicative of small digital re-
sponse window. Titration of the Lemo system with IPTG at
fixed Rhamnose concentrations (100–1000 M) produced
DRLR responses of 27–35-fold indicative an intermediate
digital-analogue response. Conversely, titrationwithRham-
nose at fixed IPTG concentrations (10–50 M) produced
DRLRs 11–14 indicating digital dose response curves. The
KRX system, which in principle should be regulated by
both Rhamnose and IPTG, displayed no significant change
in expression upon IPTG titration (Supplementary Fig-
ure S3B), was however titrated by Rhamnose in an ana-
logue dose response manner with a range of DRLRs 97–
117 at different fixed IPTG concentrations. The pBAD sys-
tem demonstrated a DRLR of 312 indicative an analogue
dose response upon arabinose titration. The caveat to this
observation is that arabinose uptake has been shown to
demonstrate significant cellular-level heterogeneity previ-
ously (30), and also in this study (Figure 4B). Global per-
formance modelling (Supplementary Figure S4) was gen-
erally consistent with the experimental data and demon-
strated that KRX expression is dominantly controlled by
Rhamnose induction, with IPTG resulting in only 1.15-fold
(1/f1) effect upon expression above Rhamnose alone.
Volume and temperature scalability performance character-
istics
The scalable performance of both t/t and tT/tT systems un-
der batch high-cell density growth culture was performed in
UY flasks at different induction temperatures. The t/t sys-
tem performed best at 30◦C after 5 h induction producing
an eGFP volumetric yield of ca. 0.7 g/l, and a 28-fold in-
duction of expression (Supplementary Table S5). This reg-
ulatory control was improved at lower temperature (265-
fold) however at higher temperature a lower maximum yield
was observed, along with a reduction in expression con-
trol (12-fold). The growth rate of the t/t system under in-
duced conditions was also greatly affected at all tempera-
tures above 20◦C, where the doubling times were more than
2-fold slower than the un-induced cells (Supplementary Ta-
ble S6). The tT/tT system (30◦C, 5 h) showed lower volu-
metric yield (ca. 0.4 g/l), but maintained a large 423-fold
induction of expression, and a 56-fold tighter basal control
than for the t/t system, consistent with the multiwell-scale
growth analysis (Table 1 and Supplementary Table S5). In
addition, the growth rate of tT/tT system was also largely
unaffected by induction, where the doubling times for both
induced and un-induced cells were consistent at all temper-
atures (Supplementary Table S6).
We additionally compared the maximal output, regula-
tory control and basal leakage for the other E. coli expres-
sion systems in UY flasks (30◦C, 5 h) (Supplementary Table
S5). Maximal expression was observed for the t/t system,
with the alternative strains expressing between 17–52% of
this under full induction conditions (Table 1). The smallest
regulatory control (max/basal) being the LysS, t/t, Lemo
and KRX systems demonstrating between 28–84 fold con-
trol (Supplementary Table S5). The pBAD system demon-
strated the next greatest dynamic range 345-fold control,
with the tT/tT system demonstrating 500-fold control (Sup-
plementary Table S5). In terms of relative basal control t/t
exhibited the greatest basal leak, with LysS and Lemo ex-
hibiting only 3-fold tighter basal control than t/t. TheKRX
system exhibited 18-fold reduction in basal leakage, whereas
pBAD and tT/tT exhibited 34 and 56-fold tighter control
respectively at 30◦C, 5 h (Table 1).
Kinetic performance characteristics
To probe the effects of regulatory control upon cellular pro-
tein expression rates, a detailed kinetic analysis was per-
formed with regular sampling of the expression cultures.
Kinetic fitting (over 0–5 h) was used to calculate the specific
rate (RFU/OD/h) and volumetric productivity (mg/l/h) of
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Figure 3. High cell density expression kinetics and performance. The t/t and tT/tT systems were grown at 30◦C in 125 ml baffled flasks and induced when
in log phase with the indicated concentrations (M) of IPTG (I) and PPDA (P). Samples were collected at different times post induction and analysed
for eGFP expression. A-B, normalized expression RFU/OD600 (bars) and absolute OD600 values (lines) were then plotted versus time for the t/t (A), and
the tT/tT systems (B). (C–D) kinetic dose-response data fitted with a four-parameter logistic function of the RFU/OD values at different time points and
induction temperatures for the t/t system titrated with IPTG (C), and the tT/tT system titrated with PPDA at a fixed IPTG concentration of 50 M (D).
The data represent the mean of at least two replicates with error bars showing standard errors.
Table 1. Expression system nomenclature and performance summary
Strain Code
Tuneability
DRLR rangea
%Max
5 h/20 h
Fold decrease of
basal 5 h/20 h Biomass Cell viabilityb
BL21(DE3) pET t/t 10 (IPTG) 100/17 1/1 moderate good
BL21(IL3) pETORS tT/tT 70–224 (PPDA)
18–22 (IPTG)
32/100 56/245 good good
BL21(DE3) pLysS pET LysS 5 (IPTG) 49/37 3/10 moderate poor
LEMO21 pET Lemo 11–14 (Rha)
27–35 (IPTG)
52/30 3/40 low moderate
KRX pET KRX 97–117 (Rha) 17/49 18/66 low moderate
BL21 pBAD pBAD 312 (Ara) 36/39 34/224 good good
Strain names, abbreviations and performance comparison for the novel expression systems reported in this study against of number of the commonly used
E. coli expression strains and systems.
aData extracted from the multiwell experiments performed at 30◦C, 3 h. All other data extracted from UY shaker flask experiments performed at 30◦C, 5
and 20 h.
b Cell viability assessed by LDH activity harvested spent media.
eGFP expression (Supplementary Figure S5 and Table S6).
The t/t system, when fully induced, rapidly produced large
amounts of protein at 30◦C (ca. 102 × 103 RFU/OD/h),
this specific rate was highly dependent upon temperature,
with these values dropping by 50% at 37◦C. Indeed the abil-
ity to tune this specific rate expressed as DRLR was 30 at
30◦C. Whereas, at lower and higher temperatures the spe-
cific rate response to IPTG operated with greater digital be-
haviour (DRLR ca. 10) (Figure 3 and Supplementary Table
S7). The tT/tT system produced protein more slowly (ca. 23
× 103 RFU/OD/h), and intriguingly was largely indepen-
dent of temperature, indicating a robust balance between
expression rate and biomass accumulation. Further the spe-
cific production rate could be precisely controlled, where the
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Figure 4. Single-cell expression analysis. (A–D) flow cytometry analysis of t/t versus IPTG (A), BL21 pBAD-eGFP versus arabinose (B), tT/tT versus
PPDA with fixed 50 M IPTG (C) and tT/tT versus IPTG with fixed 92 M PPDA (D). Cell populations were grown at 30◦C for 20 h under different
conditions, (uninduced (UI), IPTG (I) 0–250 M, PPDA (P) 0–400 M, arabinose (Ara) 0–330 M). The data show that the tT/tT system possesses
greater cellular homogeneity and stability in gene expression.
DRLR operated with consistent analogue behaviour (77–
138) across all temperatures for both PPDAand IPTG titra-
tion. We further attempted to calculate the cellular expres-
sion rate for the pBAD system, upon induction this led to a
modest initial burst (0–3 h), with max specific rate (ca. 40×
103 RFU/OD/h), after which expression reached a plateau
(3–5 h) at all inducer concentrations (Supplementary Figure
S5). The non-linear expression kinetics observed for pBAD
is possibly related to the regulation of arabinose importer
(araE) and cellular expression heterogeneity previously re-
ported (30).
Output continuance performance characteristics
At longer growth times (20 h) the t/t system only performed
well at lower temperatures, with a basal expression leak of
ca. 12% and volumetric yield of ca. 2.9 g/l at 20◦C (Sup-
plementary Table S5), indeed higher temperatures led to a
dramatic decrease in output. The tT/tT system also showed
a maximum volumetric yield of ca. 2 g/l at 20◦C, and per-
formed well at all temperatures tested with good basal con-
trol (0.2–0.5%), indicating the large window of induction
is maintained at high cell density/longer expression times.
Indeed at 30◦C the basal control of the tT/tT system was
>240-fold tighter than that of the t/t system (Table 1). The
titration of the tT/tT system can also be observed visually
by SDS-PAGE analysis of cell lysate, where eGFP expres-
sion equals ca. 30% of total cell protein (Supplementary
Figure S6A). Comparison of protein solubility of the t/t
and tT/tT systems at different expression times (Supple-
mentary Figure S6B) also indicated that the majority of the
recombinant protein is soluble, but that a greater propor-
tion of insoluble eGFP is observed for the t/t system.
At extended growth periods (20 h) for all the E. coli
expression systems induced at 30◦C, maximal expression
(RFU/OD) was observed for the tT/tT system with the
other systems expressing between 17–49% of this under full
induction conditions (Table 1). All systems based on the
BL21(DE3) parental strain demonstrated poor or modest
regulatory control (0–22-fold) due to basal leakage over the
extended growth period, KRX displayed 55-fold, whereas
pBADand tT/tT demonstrated a regulatory control of 152-
and 423-fold, respectively, indicating tight regulatory con-
trol at extended growth periods (Supplementary Table S5).
In terms of relative basal control the t/t system exhibited
the greatest basal leak, with LysS exhibiting only a 10-fold
tighter basal control than t/t. Lemo and KRX exhibited
40 and 66-fold reduction in basal leakage, and pBAD and
tT/tT exhibited 224- and 245-fold tighter control respec-
tively (Table 1). To probe for cell viability at these extended
growth periods we performed a membrane leakage anal-
ysis, using a lactate dehydrogenase activity (LDH) assay
on eGFP expression systems (Supplementary Figure S7).
Values were expressed as a percentage LDH activity ob-
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served from the media relative to chemically lysed cells. Un-
der un-induced conditions KRX and Lemo exhibited the
highest LDH activity (8–15%) indicating a modest compro-
mise in cell viability, the remaining strains demonstrated
basal LDH activities of 3–5%. Under induced conditions
the majority of the T7 RNAP based expression systems
demonstrated a 1.4–2.6-fold increase in LDH activity, with
the tT/tT exhibiting the lowest overall activity at 7.7%,
with Lemo and KRX exhibiting 12.6 and 21.0%, respec-
tively. These cell viability measurements are consistent with
the observed biomass accumulation where Lemo and KRX
biomass is 1.6- and 2.3-fold lower than tT/tT (Supplemen-
tary Table S5). The LysS system exhibited significant LDH
activity levels of 47.2% consistent with the previously re-
ported amidase activity of T7 lysozyme, constitutively ex-
pressed from pLysS (31). The lowest activity was demon-
strated by the pBAD system with LDH activity of 3.5%.
Single-cell expression analysis
In agreement with the population level data (Supplemen-
tary Table S1), flow cytometry analysis of the t/t system
20 h post-induction confirmed the high basal expression in
the absence of inducer, presumably operating via an auto-
induction mechanism (Figure 4A) (32). Increased IPTG
concentration was associated with greater heterogeneity, ex-
pressed as coefficients of variation CV (Supplementary Ta-
ble S8A). This increased variation, was due to the occur-
rence of a low intensity fluorescent sub-population of cells,
which dominated at higher IPTG concentrations (≥125
M), this observation has previously been reported (33).
This effect was not observed after a shorter induction time
(5 h) (Supplementary Figure S8).
By contrast the tT/tT system did not exhibit a signifi-
cant low intensity fluorescent subpopulation (Figure 4C,D).
In all cases at least 89% of the total population expressed
eGFP within a favourable homogenous region as indicated
by low CV values (Supplementary Table S8C and D). The
data support the population level observations that titrat-
able control was afforded with both IPTG (Figure 4C) and
PPDA (Figure 4D). Tight control over basal expression was
evidenced by a lack of leakiness within un-induced cells,
where the mean eGFP expression of the total population
remained low.
As a comparison, eGFP expression controlled by the
arabinose inducible (pBAD) system was also analysed by
flow cytometry (Figure 4B). This system demonstrated tight
basal control, titratable induction of expression and high
maximal expression intensity. However, consistent with pre-
viously reported findings (30), at sub-maximal inducer con-
centrations (0.013 mM) variation in eGFP expression was
substantial (Supplementary Table S8B).
Exemplar proteins
We sought to demonstrate the performance of the novel
systems for the expression of both toxic and clinically rel-
evant proteins. We validated the tight basal control ob-
served for the RiboTite system by controlling the expres-
sion of the toxic gene encoding levansucrase (sacB) (34–
36). In the presence of 5% sucrose, the uninduced tT/t sys-
tem maintained good cell viability, indicating tight control
over basal expression, whereas t/t system’s cell viability was
comprised, indicative of leaky basal expression (Figure 5A).
Upon induction in the absence of sucrose, we observed a 2-
order ofmagnitude decrease in cell viability for both strains,
presumably due to the burden of recombinant protein ex-
pression and/or plasmid loss (Figure 5B). Induction in the
presence of sucrose led to a pronounced loss of viability for
both strains, consistent with the efficient expression of sacB.
The titratability and tight basal control for the tT/tT sys-
tem was further demonstrated for a range of clinically rel-
evant proteins, such as the metabolite cancer target MTH1
(37,38), the cytokine Interferon 2a, and the tumour sup-
pressor protein p53 by western blot analysis (Supplemen-
tary Figure S9). For all target proteins both tight basal con-
trol and titration expression was observed for the tT/tT sys-
tem.
In order to assess whether the tight basal expression, slow
specific expression rate, and/or the tuneable homogenous
expression of the tT/tT system could offer some further ad-
vantage, we sought to explore its use for the expression of a
protein prone to insolubility and a toxic peptide. The IgG
antibody fragment scFv163R4 is produced as soluble and
insoluble forms when expressed in the cytoplasm of E. coli
(39). To challenge the tT/tT system we looked to utilize the
expanded tuneable expression range, and the slower specific
productivity of the system to influence the amount of solu-
ble scFv produced. Initially we compared the titration win-
dow for both t/t and tT/tT systems (Supplementary Fig-
ure S9B, 9C). A large window of regulation was observed
for the tT/tT system upon titration of PPDA, whereas a
narrow window of regulation upon IPTG titration was ob-
served for t/t, consistent with the eGFP expression. At low
IPTG concentration the t/t system produced scFv mostly
in the insoluble fraction, contrary to the expected, at higher
IPTG concentration the systemproduced roughly equal sol-
uble and insoluble fractions (Figure 5C). Both Lemo and
LysS systems similarly produced the scFv in both roughly
equal soluble and insoluble forms (Supplementary Figure
S9D). Intriguingly induction of the tT/tT system with low
PPDA concentrations produced mainly the in-soluble form
of scFv, however at the optimal PPDA inducer concentra-
tion (40 M), scFv was dominantly produced in soluble
form (Figure 5D).
We also expressed the type II-like bacteriocin, epider-
micin NI01 from S. epidermidis (22), previously expressed
only at 10 g/l (personal communication, M. Upton). Epi-
dermicin has potent activity against Gram-positive bac-
teria, but not against E. coli. However, accumulation in
the cytoplasm of E. coli is toxic and significantly limits
yields. The expression systems containing the plasmid en-
coding the toxic peptide were induced at different inducer
concentrations (Supplementary Figure S10). Titration of
pBAD and tT/tT is observed; this is further confirmed for
the tT/tT for western blot analysis (Supplementary Figure
S10B). In addition we sought to qualitatively compare the
production capabilities of three expression systems (Sup-
plementary Figure S10C). The specific expression yields
(target/total) were obtained by image densitometry analy-
sis, where it can be seen that tT/tT expressed epidermicin
∼13%, pBAD at ∼12%, and t/t expression at ∼6%. Fi-
nally cell growth in rich media of the expression systems
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Figure 5. Expression of toxic and challenging proteins. (A–B) Comparison of colony-forming unity (CFU) from sacB assay, CFU/ml counts for both t/t
and tT/t systems carrying a pET15-sacB plasmid were determined in the absence (A) and presence (B) of inducers with and without the addition of 5%
sucrose. In the absence of inducers (UI), expression of the sacB gene led to highly sucrose-sensitive behaviour in the t/t system, whereas upon induction
(I/P, 50 M IPTG plus 100 MPPDA) both systems displayed sensitivity. The data represent the mean of at least three replicates with error bars showing
standard deviation errors. (C–D) solubility analysis of the scFv protein, visualized by SDS-PAGE andwestern blot, of soluble (S) and insoluble (I) fractions.
t/t was induced for 3 h at 30◦C (C) and tT/tT for 20 h at 30◦C (D), with the indicated concentration of inducer.
was monitored (Supplementary Figure S10D, E). In the ab-
sence of induction, both pBAD and tT/tT reached high cell
density OD600 ∼17, and t/t demonstrated slightly compro-
mised biomass of OD600 ∼15. As toxic protein expression
can result in arrest of cell growth upon induction, an opti-
mal mid-phase induction of OD600 = 8 was selected. Induc-
tion led to a rapid halt in cell growth for all systems, leading
to a plateau in biomass accumulation (5–10 h), and then a
slow increase growth for the t/t and pBADsystems resulting
in final OD600 ∼10 (23 h), a 30–43% reduction in biomass
compared to the un-induced conditions. Whereas the tT/tT
system after the plateau in growth, recovered and continued
to grow reaching a final OD600 = 15, a biomass reduction
of only ca. 9%, relative to uninduced, and 42–52% greater
biomass than the t/t and pBAD systems.
DISCUSSION
The t/t system, operating with dual transcriptional con-
trol only, demonstrated leaky basal expression and a nar-
row dynamic range of ligand response, indicating a digital
(ON/OFF) dose response to IPTG induction. The system
was also sensitive to growth temperature, where opposing
affects were observed. Increasing temperature led initially
to a 2-fold increase in both specific yield (RFU/OD), and
specific rate (RFU/OD/h), however further temperature el-
evation to 37◦C led to 2-fold reduction in these performance
parameters. The fragility of the system was also demon-
strated by the effect of induction upon doubling times (Sup-
plementary Table S6). Furthermore, for extended growth
times under batch (UY) conditions the system performed
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poorly at temperatures above 20◦C, with loss of IPTG de-
pendent regulatory control, population heterogeneity and
reduced yield. Various attempts have been made to allevi-
ate these limitations (1,9), and both the digital response and
stoichiometry of the lac repressor-IPTG interaction have
been widely studied (40,41).
The tT/t system demonstrated robust regulatory control,
exhibiting >400-fold induction after 3 h at 30◦C (multi-
well scale), which was reasonably maintained at extended
growth times (56-fold after 20 h), conditions under which
the t/t system displayed only 65-fold and 3-fold control, re-
spectively. The system also displayed a comparable maxi-
mal expression output relative to the t/t system. Finally, a
DRLR of 79 for the tT/t system (in response to PPDA),
compared to a DRLR of 10 for the t/t system (in response
to IPTG), indicates a highly titratable analogue dose re-
sponse, demonstrating the enhanced potential of dual tran-
scriptional and translational control over T7 RNAP.
The tT/tT system at 30◦C (multiwell scale), afforded a
large induction control (ca. 850-fold), the lowest basal ex-
pression levels (0.1%), and a significantly expanded DRLR
of 245, allowing for simple and precise analogue titration
of target gene expression levels. The IPTG response be-
haviour at fixed PPDA concentrations indicates the system
functions like a rheostat, allowing regulation of the maxi-
mal output (vertical extension) without affecting basal out-
put or other expression parameters. Alternatively, varying
IPTG could attenuate both the PPDA analogue response
behaviour and max/basal expression levels. Where at low
(IPTG) transcriptional levels the PPDA sensing window
(DRLR) is greatly extended, producing horizontal scaling
of the response curves, and at high transcript levels an in-
crease in both max/basal expression is observed producing
a vertical scaling of expression response. This demonstrates
that the performance and response of the system can be pre-
cisely tuned to permit dynamic control upon addition of
small molecule inducers. At larger scale (UY shaker flasks),
the tT/tT maintained its tight basal control at both short
and extended growth periods, demonstrating>240-fold (20
h) tighter basal than t/t.
The tT/tT system performed well against all the com-
monly used E. coli expression systems used in this bench-
marking study. Across all scales and conditions the basal
control was the most tightly controlled and tunability was
best maintained for the tT/tT system. The Lys system re-
duced basal expression of 3–10-fold relative to t/t, but also
resulted in a reduced maximal expression (UY scale) and
displayed a compromised viability, most likely due to ami-
dase activity of T7 lysozyme (31). Lemo operated with
intermediate-digital titratable control, a modest reduction
in basal expression, moderate expression levels (UY scale),
but moderately poor cell viability and low biomass. Simi-
larly KRX operated with good analogue control, modest
reduction in basal, moderate expression levels, but mod-
erately poor viability and poor biomass under the condi-
tions assessed. The pBAD system operated with excellent
analogue control (DRLR = 230), impressive basal control,
and good viability and biomass, however was subject to ex-
pression heterogeneity at sub-maximal inducer concentra-
tions, consistent with previous reports (3,30). T7 RNAP-
based expression systems are known to suffer from growth
defects and compromised cell viability, likely due to the
speed of T7 RNAP, which leads to the desynchronisation of
transcription-translation (42). Of all the T7-based systems
tested tT/tT was able to grow to the highest cell density and
exhibited the least compromise to cell viability under in-
duced conditions. In terms of maximal protein expression
from shaker flasks at 30◦C the tT/tT system was only out-
performed by the BL21(DE3) based systems at short induc-
tion times (5 h), at longer induction times the tT/tT system
produced the highest specific and volumetric expression lev-
els.
Kinetic protein expression analysis (UY scale) demon-
strated that the tT/tT system operates with a lower max-
imal specific rate compared to the benchmark t/t system,
and that this rate demonstrated little dependency upon tem-
perature. Intriguingly, the specific production rate could be
tunably controlled, with consistent analogue behaviour, by
both PPDA and IPTG over the range of temperatures as-
sessed. Both tuneable control and tight basal control of
expression was maintained for extended durations far af-
ter media glucose consumption, conditions where stand-
alone lac operator/repressor systems are known to suffer
from extensive leak via catabolite de-repression (32). In ad-
dition, the system maintained tuneable expression within
a tight homogenous range across the whole cell popula-
tion in response to both inducers. It has been shown previ-
ously that lowering the expression temperature <25◦C can
enhance protein yield (43,44), and the accepted wisdom is
that lower temperature <20◦C can enhance protein solu-
bility and yield. However at temperatures ≤20◦C E. coli
growth rapidly drops, and at lower temperatures the cellular
processing capacity, e.g. chaperone activity is compromised
(45). Attempts to address this conflict have indeed been
sought by co-expression of chaperones from psychrophilic
bacterium (46). However, the ability to slow and regulate ex-
pression rate, as demonstrated with the tT/tT system, with-
out compromising cellular (enzymatic) processing capacity,
due to a drop temperature would be advantageous. Addi-
tionally on a technical level for the production of recombi-
nant proteins at a pilot or industrial scale, cooling of large
bioreactors can be a costly and technical challenge.
For the expression applications with clinically relevant
and/or toxic proteins of interest, the tT/tT system per-
formed well, enhancing the fraction of soluble scFv pro-
duced relative to the t/t system. Further the tT/tT system
demonstrated the enhanced volumetric expression of the
antimicrobial peptide epidermicin NI01 2-fold more than
t/t.
In summary, the dual transcriptional-translational reg-
ulatory cascade afforded by the tT/tT expression system,
comprising a dual lac-operator/repressor and orthogonal
riboswitch controlling both T7 RNAP and the gene of in-
terest, offers the greatest regulatory performance of all the
expression systems assessed in this study. This novel expres-
sion system provides: (i) tight control over leaky basal ex-
pression in the absence of small molecule induction, per-
mitting up to 850-fold induction; (ii) access to high levels of
induction with little or no comprise to cell growth or viabil-
ity; (iii) enhanced cellular level expression homogeneity; (iv)
predictable specific productivity rates across a range of tem-
peratures; and (v) an expanded dynamic range of ligand re-
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sponse, greatly improving the titratability of target gene ex-
pression. The PPDA inducer is readily prepared from cheap
starting materials (47), and its costs is not likely to hinder
use for large-scale expression. Other efforts to reduce the
activity and regulate T7 RNAP have included use of al-
losteric inhibition (8),more tightly controlled inducible pro-
moters (1), stress engineered mutant strains (7), repressible
allosteric regulation (9), T7 RNAP fragmentation (18,19)
and T7 promoter engineering (31). However, the approach
described here is the first report of the highly active T7
RNA polymerase being controlled at both the transcrip-
tional and translation level. This inducible synthetic sys-
tem emulates nature by using multiple points of regulatory
control, including additional post-transcriptional control
mechanisms, permitting a robust balance between expres-
sion rate (ribosome capacity) and biomass accumulation
(cellular resource) (4,6,27).
We postulate that the lower specific productivity rate of
theRiboTite system, due to the translational ON control af-
forded by the use of orthogonal riboswitches, might be use-
ful for a range of protein production, metabolic engineer-
ing and synthetic biology applications. Bymatching the rate
of protein expression to the downstream cellular process-
ing capacity, cellular viability could be maintained, whilst
maximizing both specific productivity and yield. In the case
of more complex metabolic engineering, this characteristic
would permit flux optimization by fine-tuning expression of
a specific gene within an engineered biosynthetic pathway.
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